Powered by

Omnicell Enhances Robotic IV Insourcing Offerings and Ramps up Investment in IV Automation Technology; Recent severe challenges in 503B supply creating need for novel, more reliable, and safer alternatives

Feb 03, 2020 - Business Wire
Partnership Announcement

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced significant clinical enhancements and expansion of the Company's unique IV compounding service, which combines advanced technology, clinical expertise, operational support, and workflow/analytics to address challenges in sterile compounding.

The complexities of IV compounding, including staffing, equipment, facilities, and regulation...